Article Details
Retrieved on: 2024-10-15 21:12:54
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the use of inebilizumab, a monoclonal antibody, in treating generalized myasthenia gravis, highlighting its efficacy and safety. It connects to neuroscience through its exploration of autoantibodies affecting neuromuscular junctions.
Article found on: www.medpagetoday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here